SVT-15473 - Inflammation and pain after ocular surgery - Clobetasol 0.05% nanoemulsion Rx
Product Description
Laboratorios Salvat, S.A.
-
ES -
2016On CPHI since
-
4Certificates
-
250 - 499Employees
Company types
Primary activities
.jpg)
Categories
Specifications
Laboratorios Salvat, S.A.
-
ES
-
2016On CPHI since
-
4Certificates
-
250 - 499Employees
Company types
Primary activities
More Products from Laboratorios Salvat, S.A. (21)
-
Product Monolitum Flas 15 mg & 30 mg ODT - PPI - Rx
Monolitum Flas 15mg / 30mg - ODT formulation - Pack of 14, 28, 56 orally disintegrating tablets
Monolitum Flas 30mg - Acute treatment of duodenal ulcer, gastric ulcer and oesophagitis due to gastro-oesophageal reflux. Eradication of Helicobacter pylori in patients with duodenal ulcer and benig... -
Product Urosens range - Urinary infections - FS
"The most complete range for each type of cystitis"
Urosens: MAINTENANCE in occasional urinary infections.
Urosens forte: ADJUVANT in urinary infectionsUrosens mannose: MAINTENANCE & ADJUVANT in urinary infections, very recurrent urinary infection -
Product Nurane retina - AMD - FS
A sufficient dietary intake of the nutrients contained in Nurane Retina, supplemented when necessary, aids the correct functioning of the retina. Lutein and zeaxanthin are two carotenoids with antioxidant properties which help protect our bodies from attack by free radicals. They have the following functio... -
Product Nutira range - Lactose intolerance - FS
Enables better digestion of dairy products. It helps break down lactose into its two constitutive elements (galactose and glucose) and prevents intestinal symptoms related to lactose intolerance (pain, abdominal swelling, meteorism and diarrhoea) from appearing after the consumption of any dairy product, p... -
Product Malacur
Dihydroartemisinin. Piperaquine Phosphate. Malaria
-
Product Tebarat® 0.5ml/ml - Allergic conjunctivities - single-dose vials eye drops - Rx
Tebarat® is azelastine 0.05% is indicated for the prevention and the treatment of allergic conjunctivitis. Eye drp presented in single-dose vials, preservative-free.
-
Product Clotic®- Otic Fungal Infection - Otic Rx
Clotic® is a broad-spectrum otic antimycotic agent effective against pathogenic dermatophytes, yeasts and several species of fungus, Well-recognized safety and efficacy.
The first and only treatment with clinical evidence against otomycosis. Preservative-free.
Indication: Otic fu... -
Product Ophthalmic CDMO Services
Salvat offers the best services and solutions, drawing on a long history of expertise in developing and manufacturing successful medications.
Tailored solutions to customer needs through our Ophthalmic platform: • • Customized solutions using Salvat's technology: suspensions, solutions, micellar,... -
Product Contract Development & Manufacturing Services (CDMO)
With 70 years of experience in developing and manufacturing pharmaceutical products for diverse markets, we excel in Operational Excellence, Flexibility, and Adaptability.
Salvat offers integrated CDMO services with state-of-the-art manufacturing facilities in Barcelona, Madrid, and Miami, equip... -
Product Blow-Fill-Seal Technology (BFS) Single-dose vials CDMO
Salvat specializes in developing and manufacturing sterile liquid pharmaceutical products in single-dose vials using Blow-Fill-Seal (BFS) technology.
Advantages of using Blow-Fill-Seal technology in your products:
• • Innovative format, providing differentiation for your produ... -
Product Bimeox® 0.3mg/ml - Glaucoma (Preservative-free) - Rx
Bimeox® Bimatoprost 0.3 mg/ml, a well-known prostaglandin analogue eye drop, preservative-free, presented in single-dose vials using our Blow-Fill-Seal Technology.
• Innovative format in single-dose vials • Preservative-free for better tolerability • Sterile until ope... -
Product Tanolux® 50 ug/ml - Glaucoma - Rx
Tanolux® Latanoprost 50 ug/ml, a well-known prostaglandin analogue eye drop, presented in single-dose vials using our Blow-Fill-Seal Technology.
• Innovative format in single-dose vials • No cold chain required, easy to store & carry • Vey low solvents concentration vs ...
Laboratorios Salvat, S.A. resources (2)
-
News Laboratorios Salvat inicia un estudio pediátrico pionero en Europa con su fármaco innovador SVT-15473, para el tratamiento de la inflamación y dolor tras la cirugía ocular
- Los ensayos clínicos fase III realizados en adultos confirman la eficacia y el excelente perfil de seguridad de SVT-15473 clobetasol oftálmico, formulado con IMPACT-SVT® tecnología patentada de nanoemulsiones, para el tratamiento de la inflamación y el dolor después de una cirugía ocular.
- Es el primer estudio clínico que se realiza en paciente pediátrico con un corticoide tópico oftálmico en toda Europa.
- Con el nuevo estudio que se inicia ahora y que se llevará a cabo en seis hospitales españoles se espera demostrar también su seguridad en pacientes pediátricos de 0 a 3 años.
- Con este proyecto, que ha supuesto una inversión global de más de 20 millones de euros, Laboratorios Salvat da un paso más en su estrategia de afianzarse como un actor clave en el área de oftalmología a nivel internacional.
-
Video SVT-15473 + IMPACT-SVT® Nanoemulsion technology
Salvat has developed IMPACT-SVT®, a patented nanoemulsion drug delivery technology that improves drug mucus penetration and bio-adhesion, providing excellent ocular comfort.
IMPACT-SVT® made it possible to develop SVT-15473, using the strongest corticosteroid in the global market.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance